# Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).

> **NCT05664113** · PHASE1 · RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Gastro-Intestinal Disorder

## Interventions

- **DRUG:** Fecal microbiota transplant (FMT)

## Key facts

- **NCT ID:** NCT05664113
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-07
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664113, "Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05664113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*